Test Price
2,800 AED✅ Home Collection Available
NDUFA13 Genetic Test for Hurthle Cell Thyroid Carcinoma – DHA Licensed | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited Next-Generation Sequencing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test clinical correlation with qualified genetic counsellors.
- Insurance: Direct Billing Verification – send policy details via WhatsApp at +971 54 548 8731.
This test is governed by UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields, ensuring full genomic data confidentiality and ethical use.
Test Overview & Methodology
What is the NDUFA13 Gene Test? This test employs Next-Generation Sequencing (NGS) to detect germline mutations in the NDUFA13 gene, definitively identifying hereditary risk for Hurthle cell thyroid carcinoma. It is indicated for individuals with a personal or family history of thyroid cancer and requires pre-test genetic counselling.
| Feature | Our Test (NDUFA13 NGS) | Standard Thyroid NGS Panel |
|---|---|---|
| Precision | Targeted single‑gene depth (99.9% sensitivity for NDUFA13 mutations) | Broad panel; may miss low‑frequency NDUFA13 variants |
| Methodology | CE‑marked NGS with proprietary bioinformatics pipeline | Standard NGS, often without gene‑specific optimisation |
| Turnaround | 3–4 weeks | 4–6 weeks |
| Counselling | Included pre‑test pedigree analysis | Often optional or additional |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403): “A positive NDUFA13 result must always be correlated with thyroid ultrasound and a comprehensive three‑generation family pedigree. Genetic counselling before and after testing is essential to help patients interpret the findings and make informed decisions about surveillance frequency or prophylactic interventions. This test is not diagnostic for non‑hereditary thyroid nodules.”
Medication Advisory
⚠️ Important Pre‑Test Consideration
Do not discontinue any prescribed thyroid medication, hormone therapy, or anticoagulant regimen without consulting your referring physician. This genetic test is for elective hereditary risk assessment and does not replace ongoing clinical management or emergency care.
Exclusion & Emergency Criteria
- Exclusion: Individuals unable to provide valid informed consent (e.g., acute psychiatric instability) or minors without legal guardian authorisation per UAE personal data protection regulations.
- Exclusion: Current life‑threatening condition requiring immediate intensive care or haemodynamic instability precluding safe venipuncture.
- Exclusion: Lack of clinical indication for germline NDUFA13 testing as per DHA oncogenetic referral guidelines.
- ER Red Flags: If you develop sudden neck swelling, difficulty breathing, or signs of thyroid storm (high fever, rapid heart rate, confusion) after any recent thyroid procedure, seek emergency care immediately. This genetic test is elective; it does not address acute medical crises.
Patient FAQ & Clinical Guidance
1. What exactly does the NDUFA13 genetic test tell me?
The test identifies germline mutations in the NDUFA13 gene that confer a high lifetime risk of developing Hurthle cell thyroid carcinoma. Your report will indicate whether a pathogenic variant is present, guiding personalised surveillance intervals and family screening recommendations.
2. Is a blood sample the only option, and will I need a separate genetic counselling session?
We accept whole blood, extracted DNA, or a dried blood spot on FTA card. A dedicated pre‑test genetic counselling session to construct a pedigree chart is mandatory and included in the service. Our mobile phlebotomist can collect the sample at your home between 8 AM and 11 PM daily.
3. How long do results take and what support do I get afterwards?
Your NGS report is ready in 3–4 weeks. After release, you receive a complimentary telephonic clinical guidance session to interpret results, discuss implications for family members, and plan next steps with our genetic counselling team.
UAE Regulatory & Data Privacy Adherence
All genetic data processing, storage, and sharing for this test strictly comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient genomic information is encrypted, access‑controlled, and never disclosed to third parties without explicit consent. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | NDUFA13 Gene Sequencing for Hurthle Cell Thyroid Carcinoma Risk |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks (21–28 calendar days) |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with proprietary bioinformatics pipeline |
| ICD-10-CM Code | C73 (Malignant neoplasm of thyroid gland) |
| LOINC Code | 81247-9 (Gene mutations detected in Blood by Sequencing) |
| DHA Facility License & Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians